about
The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital.Polymorphisms in ABC transporter genes and concentrations of mercury in newborns--evidence from two Mediterranean birth cohortsMeasures of outcome in metastatic breast cancer: insights from a real-world scenarioThe incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study.Impact of potential inappropriate NSAIDs use in chronic pain.Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohortHER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series.Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy.Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in FriuThe prevalence of vegetative and minimally conscious states: a systematic review and methodological appraisal.The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Cohort Study.A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma.MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors.Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.Unplanned presentations of cancer outpatients: a retrospective cohort study.Colorectal cancer risk and nitrate exposure through drinking water and diet.Polypharmacy and the use of medications in inpatients with acquired brain injury during post-acute rehabilitation: A cross-sectional study.Does psychosocial compliance have an impact on long-term outcome after heart transplantation?†.Bevacizumab and first-line chemotherapy for older patients with advanced colorectal cancer: final results of a Community-based Observational Italian Study.Prescribing practice and off-label use of psychotropic medications in post-acute brain injury rehabilitation centres: a cross-sectional survey.A case-control study of occupational exposures and systemic sclerosis.Clinical outcome of deep brain stimulation for dystonia: constant-current or constant-voltage stimulation? A non-randomized study.[Fetal and perinatal exposure to mercury and selenium: baseline evaluation of a cohort of children in Friuli Venezia Giulia, Italy].How complete is the information on preadmission psychotropic medications in inpatients with dementia? A comparison of hospital medical records with dispensing dataMigration, socio-economic status and the risk of colorectal cancer in ItalyReproductive factors and the risk of scleroderma: An Italian case-control studyPlasma amino acids patterns and age of onset of amyotrophic lateral sclerosisRecurrent respiratory infections and phagocytosis in childhoodPredictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records dataLong-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type IIThe role of admission surveillance cultures in patients requiring prolonged mechanical ventilation in the intensive care unitRisk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover studyAnticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medicationsEpidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: a retrospective population-based studyValidation of discharge diagnosis coding for amyotrophic lateral sclerosis in an Italian regional healthcare database
P50
Q33491038-8ECB49AB-E9AC-4480-9FD9-9ED31E1E3B7CQ33617898-059BA947-73EF-4F01-A9C9-481BEE669416Q33699649-FC7A6706-281D-4F77-A7DE-832868EAA536Q34742295-55CA3235-3EFD-457C-84BC-7A77931A0C7CQ35490265-0A03419D-0BA6-4E04-8C66-7DDDF087C1A8Q35853142-F393FE15-E588-48BF-A2E3-99EB0DD5B41DQ36655951-49B02E9A-49AE-4BFF-86EE-CC363A9B1E40Q38066421-01BFFCDA-9BC1-48B8-AE85-829940CBDEBAQ38130143-F4113359-D5B8-4DAB-B945-38DF266597E0Q38139846-E9702B05-2138-4B8A-81BA-6ECD2CF55D8AQ38375721-335A589A-A258-4D12-B929-FE6CA112F68CQ38407293-DF8CB26F-FE22-499F-AFE0-566E959587CAQ39022551-5E8CB078-B843-41B0-A277-E8593CA7978CQ39038413-D4A21108-ACBB-4E71-9300-99BE49154B84Q40282702-A58605B6-D0E6-492B-ADB1-59A0AC737E03Q40865865-F90B8AAF-F91D-4D0B-85EB-372FBD81599EQ40902288-8EA8E0D6-811F-47F3-8B2A-F9F5A36F170CQ41025432-AE89265D-FCB0-4603-808F-D6788893BA09Q41089275-55D62201-22C0-4C61-BF9A-5A70EBCC90DCQ41639338-F48D81F2-CB50-4E5D-8A9A-6A9B110A39BEQ47580612-C7D0125A-3FEF-45B2-8CA5-D7CB475974EBQ48650303-8C80C5B7-D9F7-4610-9BDF-967FB78E9185Q51876794-42A459C8-E009-4114-8BE8-5E2C734FD60EQ56890634-F7405CD7-2177-4F9B-B3DD-BDED98F3E294Q57560691-43248FE4-601D-4D6F-A574-86774E3C13A6Q57893169-A5BA8E7F-A474-49BA-AEDE-17087C180FB2Q58256905-72FD09DF-E023-4CAD-A7E7-68456D705009Q60997918-AD72333F-583E-4F9F-AB54-4E4A11816C60Q64041283-5D20AC5F-1A32-430A-BD20-8C59F0833738Q64042342-463F63B4-6FBA-4F01-97B8-B1E3E0E144B4Q84007558-64687AC8-8048-4586-A570-E41C81A8D03FQ87674201-184C8359-305A-4B4E-A6DA-806761CC51B5Q91564630-87F76CC7-79CC-472C-83D5-CE982B9DB456Q93088763-FA639BE0-A1F9-4B60-9E85-C137F6D61C1EQ93158972-1D6C7882-CE71-4E1D-9EFC-C1D57C53A2A4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federica Pisa
@ast
Federica Pisa
@en
Federica Pisa
@es
Federica Pisa
@nl
type
label
Federica Pisa
@ast
Federica Pisa
@en
Federica Pisa
@es
Federica Pisa
@nl
prefLabel
Federica Pisa
@ast
Federica Pisa
@en
Federica Pisa
@es
Federica Pisa
@nl
P106
P1153
6602656454
P21
P31
P496
0000-0003-0459-2616